Ashley Cordova

NVCR

Ashley Cordova serves as Chief Executive Officer at NovoCure Limited (NVCR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$996.9K

Total Sells

2 trades

$304.2K

Net Position

Net Buyer

$692.7K

Companies Traded

NVCR

Active Period

Feb 2025 – Sep 2025

3 total trades

Most Recent

Buy NVCR

Sep 5, 2025 · $996.9K

Ashley Cordova's Insider Trading at NovoCure Limited (NVCR)

Buys

1 · $996.9K

Sells

2 · $304.2K

Total Shares Bought

81,550

Total Shares Sold

15,547

NVCR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Sep 5, 2025	Buy	81,550	$12.22	$996.9K
Mar 3, 2025	Sell	2,053	$18.54	$38.1K
Feb 27, 2025	Sell	13,494	$19.72	$266.1K

Related Insiders

Mukund Paravasthu

Chief Operating Officer

NVCRSell · Jan 11, 2026

Christoph Brackmann

Chief Financial Officer

NVCRSell · Nov 4, 2025

Frank X Leonard

EVP, Pres., Novocure Oncology

NVCRSell · Nov 1, 2025

Michal Nath Puri

Chief Human Resources Officer

NVCRSell · Oct 31, 2025

Martin J. Madden

Director

NVCRSell · Jun 3, 2025

Allyson J Ocean

Director

NVCRSell · Jun 3, 2025

Timothy J Scannell

Director

NVCRSell · Jun 3, 2025

Kristin Stafford

Director

NVCRSell · Jun 3, 2025

Explore More Insider Trading Data

NVCR Insider Trading Activity

View all insider trades at NovoCure Limited

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity